Suppressor of Fused Inhibits Skin Wound Healing.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101590593 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2162-1918 (Print) Linking ISSN: 21621918 NLM ISO Abbreviation: Adv Wound Care (New Rochelle)
    • Publication Information:
      Original Publication: New Rochelle, N.Y. : Mary Ann Liebert, Inc.
    • Subject Terms:
    • Abstract:
      Objectives: To investigate the effect of suppressor of fused (Sufu) on epidermal and dermal cellular properties and in wound healing. Approach: Transgenic (TG) mice overexpressing human Sufu (hSufu) in the epidermis were applied to investigate the effects of Sufu on epidermal and dermal cellular properties and in wound healing. Results: Histological staining revealed a reduction of epidermal and dermal thickness and an increase of hypodermal adipose tissue in homozygous K14-hSufu TG mice when compared with wild-type (WT) controls. TG mice exhibited significantly delayed skin wound healing. Moreover, the migratory and proliferative capabilities of cultured keratinocytes were decreased in K14-hSufuTG mice. Transforming growth factor-β treatment increased the expression of α-smooth muscle actin more in WT than in TG fibroblasts. Sufu overexpression significantly decreased the expression of β-catenin, glioma transcription factor 1 (Gli1), and matrix metalloproteinase-3 in wounds of K14-hSufu TG mice when compared with controls, probably indicating a delaying effect of Sufu on wound healing via blocking the hedgehog (Hh)/Gli and Wnt/β-catenin pathway. Innovation: Our results indicate a new property of Sufu in the process of skin wound healing. It provides an important basis for Sufu as a potential target for skin wound healing. Conclusion: Our findings suggest that Sufu overexpression in the epidermis impairs wound healing via dampening the Hh/Gli and Wnt/β-catenin signaling pathway. These data provide an important basis for further analyses of Sufu in skin wound healing.
      Competing Interests: The article was written by the authors and ghostwriting services were not used.
      (Copyright 2020, Mary Ann Liebert, Inc., publishers.)
    • References:
      Genomics. 2006 May;87(5):616-32. (PMID: 16434164)
      Arthritis Rheum. 2011 Jun;63(6):1707-17. (PMID: 21370225)
      Int J Dermatol. 2016 Jun;55(6):620-8. (PMID: 26547800)
      Exp Cell Res. 2005 Mar 10;304(1):274-86. (PMID: 15707592)
      J Invest Dermatol. 2014 Jul;134(7):2026-2035. (PMID: 24522432)
      Matrix Biol. 2011 May;30(4):290-300. (PMID: 21539913)
      J Dermatol. 2001 Oct;28(10):521-34. (PMID: 11732719)
      J Cell Biol. 1993 Jul;122(1):103-11. (PMID: 8314838)
      Tumour Biol. 2016 Oct 17;:. (PMID: 27752995)
      Science. 1997 Apr 4;276(5309):75-81. (PMID: 9082989)
      Methods Mol Biol. 2008;468:5-15. (PMID: 19099242)
      Dev Biol. 2014 Aug 15;392(2):324-33. (PMID: 24886827)
      Oncotarget. 2014 Nov 30;5(22):11681-94. (PMID: 25373737)
      EMBO J. 1999 Sep 1;18(17):4645-56. (PMID: 10469644)
      J Cell Sci. 2009 Jun 1;122(Pt 11):1778-87. (PMID: 19435806)
      Wound Repair Regen. 2008 Nov-Dec;16(6):768-73. (PMID: 19128247)
      Nature. 2008 May 15;453(7193):314-21. (PMID: 18480812)
      N Engl J Med. 1999 Sep 2;341(10):738-46. (PMID: 10471461)
      Dev Cell. 2006 Feb;10(2):187-97. (PMID: 16459298)
      J Biol Chem. 2001 Oct 26;276(43):40113-9. (PMID: 11477086)
      Acta Crystallogr D Biol Crystallogr. 2013 Dec;69(Pt 12):2563-79. (PMID: 24311597)
      Cell Mol Life Sci. 2013 Jun;70(12):2205-20. (PMID: 23334186)
      Nat Cell Biol. 1999 Sep;1(5):312-9. (PMID: 10559945)
      Bone. 2015 Dec;81:524-532. (PMID: 26348666)
      Discov Med. 2016 Nov;22(122):311-318. (PMID: 28009972)
      J Cell Sci. 1999 Dec;112 ( Pt 23):4437-48. (PMID: 10564661)
      Proc Natl Acad Sci U S A. 2002 May 14;99(10):6973-8. (PMID: 11983872)
      J Neurosci. 2009 Aug 19;29(33):10299-308. (PMID: 19692604)
      Mol Cell Biol. 2004 Oct;24(19):8627-41. (PMID: 15367681)
      Genes Dev. 2010 Apr 1;24(7):670-82. (PMID: 20360384)
      Oncogene. 2007 Sep 27;26(44):6442-7. (PMID: 17452975)
      Am J Pathol. 2005 Jul;167(1):59-69. (PMID: 15972952)
      Biochem Biophys Res Commun. 2009 Jan 9;378(2):149-51. (PMID: 19013436)
      Bone Marrow Transplant. 2018 Apr;53(4):377-382. (PMID: 29330404)
      Lab Invest. 2005 Mar;85(3):416-25. (PMID: 15654359)
      J Cell Sci. 2003 Aug 1;116(Pt 15):3227-38. (PMID: 12829742)
      Nat Rev Mol Cell Biol. 2002 May;3(5):349-63. (PMID: 11988769)
      Ann Surg. 1999 Aug;230(2):260-5. (PMID: 10450741)
      Pancreatology. 2008;8(3):227-9. (PMID: 18497536)
      J Cell Sci. 2002 Jul 1;115(Pt 13):2639-50. (PMID: 12077355)
      Am J Physiol Cell Physiol. 2000 Jul;279(1):C147-57. (PMID: 10898726)
    • Contributed Indexing:
      Keywords: skin; suppressor of fused; transgenic mouse; wound healing; β-catenin
    • Accession Number:
      0 (Hedgehog Proteins)
      0 (Repressor Proteins)
      0 (Sufu protein, mouse)
      0 (Transforming Growth Factor beta)
    • Publication Date:
      Date Created: 20200401 Date Completed: 20201125 Latest Revision: 20201125
    • Publication Date:
      20240105
    • Accession Number:
      PMC7099415
    • Accession Number:
      10.1089/wound.2018.0890
    • Accession Number:
      32226648